Hepion Pharmaceuticals (HEPA) Ownership - Who owns Hepion Pharmaceuticals?

Profile

Industry
N/A
Address
399 Thornall Street
Phone
+1 732 902-4000
Employees
25
Web
https://www.hepionpharma.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
5.86M
P/E Ratio
N/A
Total Cash
13.11M
Projected Growth
N/A
Total Debt
175.27K
Revenue
N/A
Risk (Beta)
1.75
Dividend Yield
N/A
Total Cash/Share
2.39
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price

Fundamentals

HEPA
Capitalization
5.86M
P/E Ratio
N/A
Risk (Beta)
1.75
Dividend Yield
N/A
Total Cash
13.1M
Total Cash/Share
2.39
Total Debt
175K
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
5.83M
P/B Ratio
1.01
Cash Flow
N/A
Earnings
-9.4
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
547
Current Ratio
5.99
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-41.81M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-117.64
Shares Held By Institutions
2.08M
Shares Outstanding - Current
5.47M
Total Liabilities
8.47M
Total Volume MTD
N/A
Value
1
Gain YTD
-66.975
View a ticker or compare two or three
HEPA
Daily Signal changed days ago
Gain/Loss if shorted
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

a pharmaceutical company, which engages in the development and commercialization of pleiotropic drug therapy for the treatment of chronic liver disease

Industry Biotechnology

Profile
Fundamentals
Details
Industry
N/A
Address
399 Thornall Street
Phone
+1 732 902-4000
Employees
25
Web
https://www.hepionpharma.com